Brian P. Chekal
Pfizer (United States)(US)
Publications by Year
Research Areas
Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Polymer crystallization and properties, Advanced Polymer Synthesis and Characterization, Polymer Science and PVC
Most-Cited Works
- → Development of a Targeted Polymorph Screening Approach for a Complex Polymorphic and Highly Solvating API(2010)135 cited
- → The Challenges of Developing an API Crystallization Process for a Complex Polymorphic and Highly Solvating System. Part I(2009)69 cited
- → Development of an Efficient Pd-Catalyzed Coupling Process for Axitinib(2013)66 cited
- → Relationship between Chain Length and the Concentration Dependence of Polymer and Oligomer Self-Diffusion in Solution(2002)34 cited
- → A Thermodynamic-Based Approach to Analyzing a Highly Solvating Polymorphic System: The Desolvation Window Method(2010)20 cited
- → Palbociclib Commercial Manufacturing Process Development. Part III. Deprotection Followed by Crystallization for API Particle Property Control(2016)19 cited
- → Development of the Commercial Route for the Manufacture of a 5-Lipoxygenase Inhibitor PF-04191834(2015)14 cited
- → Development of Migita Couplings for the Manufacture of a 5‐Lipoxygenase Inhibitor(2003)1 cited
- The strength of the gel effect in free radical polymerization: interplay of polymer physics and chain transfer(2000)
- → CCDC 773992: Experimental Crystal Structure Determination(2011)